(Date:1/8/2009)... Be Revealed Friday, January 9 , , WASHINGTON,... Employees International Union (SEIU) President An...ternational Executive Board to discuss the forced ...rs out of SEIU United Healthcare Workers-West (UHW...nal decision until tomorrow. , , According to r...
(Date:1/8/2009)...atal Solution Key Factor in Decision for Florida M...Fla., Jan. 8 Allscripts ... of the largest multi-specialty group practices in...scripts Enterprise(TM) Electronic Health Record (E... 18 offices across Central Florida. , , (Logo...
(Date:1/8/2009).... 8 Hanger Orthopedic Gr...at throughout the fourth quarter of 2008 it acquir...cky Mountain Orthotic-Prosthetics Center, Riessen,...Coast Orthotics & Prosthetics, and Orthopedic ...dd patient care centers to existing markets in Mai...
(Date:1/8/2009)... The Pew Charitable Trus...ed director, chemical and food safety programs, in...lson, who was formerly deputy staff director and g...ent and Public Works, brings nearly 25 years of ex...cacy to Pew. , , "We are excited to be joined ...
Breaking Medicine News(10 mins):Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2...ws that Soy milks, yogurts and desserts grew by 22...e even more health-conscious and more aware of foo...at based on the current trend sales are further ex.... According to the survey researchers also say the...
...the difference in genes might be responsible for t...yperactivity disorder (ADHD) differ in reacting to...s from University of Illinois at Chicago, had foun... a dopamine transporter gene -- a variant known to...
...e (TAI) will soon begin training sex workers in th...as been accelerated following the provision of $12...ve years. // The decision to train sex workers on ...been taken up after the representatives of sex wor...
...e nearly twice as prevalent in high schools in the...iddle school students admit that drugs are used, k...schools where drugs are widely available are three...marijuana and twice as likely to use alcohol than ...
Other Medicine News:(Date:1/8/2009)...LEUVEN, Belgium, January 9 /PRNewswire-FirstCall/ ...udied in the Treatment of,Vitreomacular Adhesion ...ronext Brussels: THR), a biotechnology company,fo...scular disease and,cancer, announces today that i...icroplasmin for the non-surgical treatment of back...
(Date:1/8/2009)...RIDGE, Mass. and COLUMBUS, Ohio, Jan. 8 /PRNewswir...f proprietary nucleic acid assays, today announced...K Viral Quantitative Assay are complete. , , U...ion, linearity, specificity and reproducibility an...re determined. The data obtain agreed with interna...
(Date:1/7/2009)... Preterm Infants Drive the Increase , , WHITE P... government statistics confirm that the decades-lo...ntinues, putting more infants than ever at increas...arch of Dimes. , , Nearly 543,000 babies were b...nter for Health Statistics, which today released "...
(Date:1/7/2009)...OXFORD, England, January 7 Circass...used on allergy and critical care, today,announce...ved in 2008 with,its ToleroMune(R) anti-allergy t...recruitment for a further phase II clinical trial ...anada, has recruited 120 patients with confirmed,...
Breaking Medicine Technology:ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Preterm Births Rise 36 Percent Since Early 1980s 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure Atrial Fibrillation and Ventricular Arrhyt 776 1ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure Atrial Fibrillation and Ventricular Arrhyt 776 2ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure Atrial Fibrillation and Ventricular Arrhyt 776 3ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure Atrial Fibrillation and Ventricular Arrhyt 776 4ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure Atrial Fibrillation and Ventricular Arrhyt 776 5TriWest Contributes 2450 000 to Bob Woodruff Family Fund for Traumatic Brain Injury 5706 1TriWest Contributes 2450 000 to Bob Woodruff Family Fund for Traumatic Brain Injury 5706 2The HealthCentral Networks MyDiabetesCentral com Promotes Awareness of Diabetes 5702 1The HealthCentral Networks MyDiabetesCentral com Promotes Awareness of Diabetes 5702 2The HealthCentral Networks MyDiabetesCentral com Promotes Awareness of Diabetes 5702 3FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation 5698 1FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation 5698 2FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation 5698 3...ent with ISIS 301012 produced at least 45% additio...ded to,maximally-tolerated lipid-lowering therapie...tCall/ -- Isis,Pharmaceuticals, Inc. announced upd...al of ISIS 301012 in patients with homozygous,fami...of which were,presented in March at the of Cardiol...
...from Phase III pivotal trial demonstrate safety an...rol fumarate for,patients with moderate to severe ...- Dey, L.P. announced,that two clinical data prese...ence of the American Thoracic Society (ATS) on,Sun...o. The,presentations will detail Phase III clinica...
Other Medicine Technology:Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4The PK Plasma-CISE™ (wire electrodes) and Plasma-CUT™ (coiled electrodes) are single use devices that produce precise, consistent tissue cutting with minimal thermal spread and Vapor seal
...gle use device that produces rapid, consistent, pr...nd vapor sealing of adjacent tissue for prostatic ...ccation. Often referred to as PlasmaKinetic vapori...the urologist the control needed to achieve the an...
Medium Surgical Clips. 6 clips per cartridge. Box of 30 cartridges with a total of 180 titanium clips per box. For secure vasal and other occlusion.
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips.
Medicine Products: